In our September World Campus session, Paul Roepman (Hartwig Medical Foundation) explained how whole-genome sequencing is changing cancer care. What began in the Netherlands as a research effort in 2016 has grown into a clinical service that now delivers results in just two weeks.

Paul showed how whole-genome data can uncover hidden drivers and biomarkers, improve diagnosis in cancers of unknown primary, and directly guide treatment. In one case, a presumed lung cancer was reclassified and led to an effective targeted therapy.

He also shared how Hartwig is building multi-layered clinical reports, smarter trial matching, and real-world evidence projects. Together, these advances point toward a future where genomics and AI reshape cancer care.

👉 You can watch his full presentation on YouTube: